Bystolic (Allergan USA, Inc.)
Welcome to the PulseAid listing for the Bystolic drug offered from Allergan USA, Inc.. This Adrenergic beta-Antagonists [MoA],beta-Adrenergic Blocker [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Allergan USA, Inc. |
| NON-PROPRIETARY NAME: | nebivolol hydrochloride |
| SUBSTANCE NAME: | NEBIVOLOL HYDROCHLORIDE |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Adrenergic beta-Antagonists [MoA],beta-Adrenergic Blocker [EPC] |
| ROUTE: | ORAL |
| DOSAGE FORM: | TABLET |
| MARKETING CATEGORY NAME: | NDA |
| START MARKETING DATE: | 2008-01-22 |
| END MARKETING DATE: | 0000-00-00 |
Bystolic HUMAN PRESCRIPTION DRUG Details:
| Item Description | Bystolic from Allergan USA, Inc. |
| LABELER NAME: | Allergan USA, Inc. |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 2.5(mg/1) |
| START MARKETING DATE: | 2008-01-22 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 0456-1402_71e58374-ca24-4cd9-8cb0-3879a07bb027 |
| PRODUCT NDC: | 0456-1402 |
| APPLICATION NUMBER: | NDA021742 |
Other NEBIVOLOL HYDROCHLORIDE Pharmaceutical Manufacturers / Labelers:
